Shir for Life and ICRF partner to fund neuroblastoma tumor microbiome research
Shir for Life and ICRF are jointly funding a Weizmann Institute project investigating bacteria within neuroblastoma tumors and their potential effects on treatment response.
Shir for Life and Israel Cancer Research Fund (ICRF) are jointly funding a three-year, $180,000 Project Grant for Prof. Ravid Straussman, MD, PhD, at the Weizmann Institute of Science in Rehovot, Israel.
The project, Characterization of the Neuroblastoma Microbiome and Its Effects on the Response to Therapy, examines whether bacteria within neuroblastoma tumors influence the disease and its response to treatment.
Research in other cancers has shown that bacteria inside tumors can affect immune responses and treatment effectiveness. Their role in neuroblastoma remains largely unexplored.
“In neuroblastoma, almost nothing is known about their presence or role,” said Prof. Straussman.
His team’s preliminary findings suggest that bacteria are present in most of the neuroblastoma tumors studied, with their presence associated with patient survival. The researchers will examine samples from several hospitals to identify the bacterial species, map their locations and investigate how these findings relate to immune activity and clinical outcomes.
Using neuroblastoma models, the team will then test whether particular bacteria increase resistance or sensitivity to standard treatments, and whether targeting them could improve treatment effects. This is research into a potential route to better treatment strategies.
“For families facing neuroblastoma, every unanswered question matters,” said Einat Dado Baralia, Founder of Shir for Life.
For Shir for Life, this investment connects the needs of families with researchers working to answer important questions about the disease.
Alan Herman, ICRF Executive Director, emphasized the research’s potential and said the collaboration would help ICRF “expand our investment” in this area.
We are grateful to ICRF and to our supporters for helping make this work possible.
Recent posts
A Night for the Next Breakthrough: Our 2026 Gala
Shir for Life and ICRF partner to fund neuroblastoma tumor microbiome research
From One Family’s Loss to a Global Movement for Children With Neuroblastoma